Phase 1 Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old (including those ages exactly)
- You have been diagnosed with ALS (either "definite" or "probable") based on a specific set of recognised diagnostic guidelines
- Your lung breathing capacity (measured by a breathing test called FVC) is at least 70% of the normal expected value for someone your age and size
- If you are able to father or carry a child, you must agree to use effective non-hormonal contraception from signing the consent form until 6 months after the trial ends
- You are willing to take part voluntarily and are able to read and sign a consent form
Who may not be able to join:
- You have muscle weakness that may be caused by something other than ALS
- Your body mass index (a measure of body weight relative to height) is below 18.5, meaning you may be considered underweight
- You have a condition called primary lateral sclerosis where only the upper part of your nervous system is affected
- You have a significant mental health condition that the doctor feels could affect the trial results
- You have another disease affecting your nerves or muscles, such as myasthenia gravis or a metabolic muscle condition
- You have an autoimmune disease with severe uncontrolled joint problems or other issues that the doctor feels could affect the trial results
- You had a serious infection requiring prescription medication (antibiotics, antivirals, or antifungals) within the 2 weeks before your screening appointment, and it is not yet under control
- You have been diagnosed with active tuberculosis (TB) or have been treated for suspected TB
- You have a serious lung disease that the doctor feels could affect the trial results
- You have high blood pressure that is not well controlled
- You have had or currently have any heart problems (confirm with trial site)
- You have a history of liver cirrhosis, long-term hepatitis, or abnormal liver function results at screening (confirm with trial site)
- You have a history of chronic kidney disease
- You have a history of abnormal bleeding or blood clotting, or you are currently taking blood-thinning medication
- You tested positive at screening for active hepatitis B, active hepatitis C, HIV, or syphilis
- You have had a serious injury or surgery that the doctor feels could affect the trial results
- You have a condition that makes a lumbar puncture (spinal tap) unsafe for you, such as an infection near the injection site or raised pressure in your skull
- You have had a cancer diagnosis within the past 5 years, or you are currently receiving cancer treatment
- You have taken part in another clinical trial within the 3 months before your screening appointment
- You are currently pregnant or breastfeeding
- The trial doctor has another reason they feel you are not suitable for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 21 64027719
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The incidence of XS228CN-related adverse events (AEs) and serious adverse events (SAEs) within 28 days after the last administration in ALS patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.